GT Biopharma (GTBP) had the best year between 2010 and 2014 by a US stock in 2012, returning 3,044,698,370%.
| ASSET | YEAR | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 2012 | 3,044,698,370% |
PCB Bancorp (PCB) | 2014 | 527,363,000% |
Castellum (CTM) | 2011 | 6,521,639.13% |
Sequans Communications (SQNS) | 2011 | 3,349,297.59% |
QXO (QXO) | 2012 | 1,151,950% |
Inventrust Properties (IVT) | 2014 | 1,067,615% |
Nutex Health (NUTX) | 2013 | 749,900.2% |
Aris Mining (ARMN) | 2010 | 184,239.52% |
Ferguson (FERG) | 2010 | 140,764.58% |
PetVivo (PETV) | 2014 | 64,689.33% |
Intellinetics (INLX) | 2012 | 8,066.67% |
BTCS (BTCS) | 2010 | 5,920.01% |
Nova Lifestyle I (NVFY) | 2011 | 2,733.33% |
InnovAge (INNV) | 2011 | 2,566.67% |
Ainos (AIMD) | 2014 | 2,057.89% |
Par Pacific (PARR) | 2012 | 1,900% |
ClearOne (CLRO) | 2010 | 1,720.75% |
Versus Systems Inc. (VS) | 2011 | 1,473% |
Heritage Global (HGBL) | 2011 | 1,400% |
Actinium Pharmaceuticals (ATNM) | 2012 | 1,400% |
Data Storage (DTST) | 2011 | 1,328.57% |
DarioHealth (DRIO) | 2013 | 1,250% |
Vivakor (VIVK) | 2012 | 1,224.46% |
NextTrip (NTRP) | 2013 | 1,175.86% |
Predictive Oncology (POAI) | 2010 | 1,149.84% |
